Experienced in Otitis

Peter Csonka

Tampere, FI 
Experienced in Otitis
Tampere, FI 
OverviewLocationsClinical Research

Overview

Peter Csonka practices in Tampere, Finland. Mr. Csonka is rated as an Experienced expert by MediFind in the treatment of Otitis. His top areas of expertise are Stridor, Asthma, Bronchitis, and Childhood Iron Deficiency Anemia.

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Otitis.

Gender
Male

Locations

Tampere, 33100, Finland
Other Locations
Helsinki, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Randomized, Observer-blind, Placebo Controlled, Multicenter Clinical Trial to Assess Herpes Zoster Recurrence and the Reactogenicity, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine (HZ/su) When Administered Intramuscularly on a 0 and 2 Month Schedule to Adults ≥50 Years of Age With a Prior Episode of Herpes Zoster
A Phase III, Randomized, Observer-blind, Placebo Controlled, Multicenter Clinical Trial to Assess Herpes Zoster Recurrence and the Reactogenicity, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine (HZ/su) When Administered Intramuscularly on a 0 and 2 Month Schedule to Adults ≥50 Years of Age With a Prior Episode of Herpes Zoster
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Biological, Drug
Study Drug: Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A)
Study Phase: Phase 3
Immunogenicity and Safety Study of GSK's Investigational Vaccine (GSK3277511A) When Administered in Healthy Smokers and Ex-smokers Following Receipt of Shingrix Vaccine
Immunogenicity and Safety Study of GSK's Investigational Vaccine (GSK3277511A) When Administered in Healthy Smokers and Ex-smokers Following Receipt of Shingrix Vaccine
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological
Study Phase: Phase 2
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Investigational Unadjuvanted RSV Maternal Vaccine Compared to Placebo When Administered to Healthy Non-pregnant Women.
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Investigational Unadjuvanted RSV Maternal Vaccine Compared to Placebo When Administered to Healthy Non-pregnant Women.
Enrollment Status: Completed
Publish Date: August 13, 2021
Intervention Type: Biological, Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

33 Total Publications

Cough medicine prescriptions for children by physician specialty and healthcare sector: a Finnish population-based nationwide register study.
Cough medicine prescriptions for children by physician specialty and healthcare sector: a Finnish population-based nationwide register study.
Journal: European journal of pediatrics
Published: May 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Csonka's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile